Coronary artery calcification (CAC) is a well established surrogate marker of the total burden of coronary atherosclerosis \[[@B1]-[@B3]\]. Large prospective studies consistently demonstrated that higher CAC scores are associated with increased risk for coronary artery disease (CAD) related events \[[@B4],[@B5]\] and that addition of CAC score to traditional risk factors improves risk stratification \[[@B5],[@B6]\]. Previously, we \[[@B7],[@B8]\] and others \[[@B9]\] have suggested that subjects with extensive CAC (ECAC) are at increased risk of stable angina but not of acute coronary syndrome, compared to the those with the lower CAC scores.Diabetes mellitus (DM) represents a strong risk factor for CAD, albeit its association with CAC is controversial. While a number of studies have found significant relationship between high CAC and DM \[[@B10]-[@B13]\], the Multi-Ethnic Study of Atherosclerosis (MESA) did not confirm this association \[[@B9]\]. In an aim to elucidate these controversies we sought to investigate the long-term CAD outcome (stratified according to chronic or acute events) in relation to degree of CAC in patients with and without DM undergoing our annual cheek-up outpatient clinic.

Material and methods
====================

Patient selection
-----------------

Seven hundred and forty five consecutive subjects who consented to perform a cardiac computed tomography (CT) for coronary calcium evaluation were recruited from our annual cheek-up clinic between January 2001 and January 2002. The inclusion criteria for screening were men above 40 and women above 50 years free of cardiovascular disease. Those who had at least one year of follow-up were included in the present analysis. Seventy six subjects who never returned to the annual check-up were excluded and two others were excluded since an acute MI was found in their files before the study entry. The remaining 667 subjects comprised our study group. All underwent CT at baseline visit and were then yearly evaluated. The development of events was finally assessed on February 2011. So, the follow-up period was until the first diagnosis of event, death, last annual check --up, or 31 January 2011, providing a maximum follow-up of 10 years, mean 6.3 ±3.4 years.

Events definition
-----------------

Only first coronary events were analyzed. We defined acute event as first acute MI or hospitalization for a new unstable angina. Chronic event was defined as positive stress test on the routine annual check-up, with or without chest pain, with a consequent elective coronary catheterization resulting in percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG).

Follow-up
---------

Events were recorded from the files of the annual check-up program in our institute and were verified by the available documentation. Data on mortality and cause of death were available for all participants from the registry of the Ministry of Internal Affairs. A written informed consent was obtained from all patients and the entire study protocol was approved by the Sheba Medical Center Helsinki Committee.

Annual check-up
---------------

All subjects were clinically evaluated at baseline and then annually, and a detailed medical history and standard physical examination were performed. The following variables were recorded: age, height, weight, concomitant diseases, smoking habits, and laboratory evaluation. Estimated glomerular filtration rate (eGFR) was calculated according to the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation \[[@B14]\].

Coronary CT
-----------

All CT scans were performed on a dual-detector spiral CT without ECG gating and without contrast injection. Scanning protocol and CAC measuring were done according to a previously published protocol using the modified Agatston method \[[@B15]\]. Total CAC score was the sum of all the individual calcific lesions identified within the area of the coronary arteries. The reproducibility of calcification scoring by this method is high, with an intra class correlation coefficient of 0.99 and of 0.94 for inter-observer agreement \[[@B16]\]. The following 4 CAC categories were distinguished: absence of CAC; mild-moderate CAC: 1--100 AU; high CAC: 101--600 AU and very high ECAC score: above 600 AU, which corresponds to the 95^th^ percentile in our cohort.

A TCS \> 0 was considered positive for the presence of any CAC. The number of coronary vessels with CAC was recorded for each subject and defined as having at least one calcific lesion in one of the 4 regions: main left artery, left anterior descending artery (LAD) and its branches, left circumflex artery (LCX) and its branches and right coronary artery (RCA) and its branches.

Assessment of cardiovascular risk factors
-----------------------------------------

Height and weight were measured with participants wearing light clothing without shoes. The body mass index (BMI) was calculated as weight (Kg) divided by the square of the height. Blood pressure (BP) was measured in the seated position after 3 minutes of rest. Hypertension was defined when BP levels were twice ≥140 mm Hg for systolic BP and/or ≥90 mm Hg for diastolic BP or a history of hypertension was reported or when the subject was on antihypertensive medications. Diabetes mellitus (DM) was defined when fasting plasma glucose was on 2 occasions greater than 126 mg/dL (7.0 mmol/L), a history of DM was reported or when the patient was on insulin or oral hypoglycemic medications. Hypercholesterolemia was defined when measured total cholesterol was \> 250 mg/dl, or when the patient reported medication with cholesterol lowering agents. Smoking status was determined according to the questionnaire.

Statistical methods
-------------------

Data were analyzed with IBM SPSS software version 21.0 and were presented as frequencies and percentages for categorical variables and as mean and standard deviation for continuous variables. Significance levels were set at 0.05. The distributions of continuous variables in the study were examined using the Kolmogorov-Smirnov non-parametric test. To demonstrate the differences between the event groups (no event, chronic event and acute event), Chi-Square tests were analyzed for differences in categorical baseline characteristics and incidence of events between the groups. One-way ANOVA tests were performed for continuous characteristic including TCS values, following by analysis of covariance (ANCOVA) to adjust for age as a potential covariate.

Results
=======

The mean period of follow-up was 6.3 ±3.4 year. During this period 628 subjects (94%) were free from any cardiac events (Group I). Throughout follow up 39 (6%) of patients experienced a cardiac event: 18 of them suffered acute events (13 acute MI and 5 unstable angina pectoris -- Group II) and in 21 of them chronic events were documented (Group III). Eight patients died without having any known prior cardiac event (non-cardiac death).

The baseline characteristics of the participants are given in Table [1](#T1){ref-type="table"}. Patients with events were older than those without and those with chronic events were older than those with acute. The frequency of hypertension was twice higher among those with chronic than in those with acute event and no events. All the other clinical and laboratory parameters were not statistically different between study groups. There were 67 patients with and 600 patients without diabetes in our study. It should be pointed out that 78% of the patients with DM had CAC (TCS above zero) vs. 50% of patients without DM (p \< 0.001).

###### 

Baseline characteristics of the study population

  **Characteristics**         **No event N = 628**   **Acute event N = 18**   **Chronic event N = 21**   **p value**
  --------------------------- ---------------------- ------------------------ -------------------------- -------------
  Age                         55 ± 7.2               57 ± 8.2                 60 ± 7.7                   0.007
  Male gender                 526 (84)               17 (94)                  21 (100)                   0.073
  BMI (kg/m2)                 27.0 ± 3.5             27.7 ± 4.0               26.2 ± 2.7                 0.395
  SBP (mmHg)                  126 ± 17               124 ± 15                 130 ±13                    0.444
  DBP (mmHg)                  79 ± 9                 78 ± 9                   79 ± 6                     0.906
  Hypertension                163 (26)               5 (28)                   12 (57)                    0.007
  Diabetes                    60 (10)                3 (17)                   4 (19)                     0.232
  Current smokers             106 (22)               4 (33)                   5 (31)                     0.454
  Chronic renal failure       14 (2)                 1 (6)                    1 (5)                      0.511
  CAD family history          162 (26)               3 (18)                   7 (35)                     0.486
  Hyperlipidemia              284 (47)               9 (50)                   12 (60)                    0.475
  Urea (mg/dl)                33 ± 7.7               35 ± 7.7                 32 ± 5.7                   0.557
  Creatinine (mg/dl)          1.07 ± 0.15            1.08 ± 0.17              1.13 ± 0.11                0.179
  Glucose (mg/dl)             99 ± 23                96 ± 18                  101 ± 21                   0.761
  Calcium (mg/dl)             9.6 ± 0.45             9.6 ± 0.46               9.6 ± 0.50                 0.908
  Phosphorus (mg/dl)          3.02 ± 0.50            2.76 ± 0.27              3.0 ± 0.69                 0.088
  Triglyceride (mg/dl)        143 ± 79               156 ± 63                 133 ± 58                   0.671
  Total cholesterol (mg/dl)                                                                               
  HDL-cholesterol (mg/dl)     45 ±12                 40 ± 5                   45 1 ± 3                   0.243
  LDL-cholesterol (mg/dl)     127 ± 29               127 ± 37                 127 ± 26                   0.999

Data are number (%) of patients or mean ± SD.

The CAC characteristics of patients are given in Table [2](#T2){ref-type="table"}. Among subjects without events half had CAC (TCS \> 0) while all those with chronic and three quarter of the acute events group had CAC. Equally, the mean CAC score was 10 times higher in the chronic events group than in those without events (914 vs. 93 AU) and 17 times higher than the mean TCS of the acute group (914 vs. 55 AU). Ninety five percent of the patients with chronic events had more than one calcified vessel compared to 67% of the patients with acute events and only 30% of those without events (p \< 0.001).

###### 

The CAC characteristics according to outcome during follow-up

  **Variable**      **No event N = 628**   **Acute event N = 18**   **Chronic event N = 21**   **p value**
  ----------------- ---------------------- ------------------------ -------------------------- -------------
  TCS mean (SD)     93 ± 276               55 ± 62                  914 ± 660                  \<0.001
  TCS \>0           311 (50)               13 (72)                  21 (100)                   \<0.001
  CV \> 1           187 (30)               12 (67)                  20 (95)                    \<0.001
  No CV mean (SD)   1.02 ± 1.15            1.72 ± 1.23              3.05 ± 0.74                \<0.001

TCS - Total calcium score (AU); CV - calcified vessel \>1 - more than one calcified major coronary vessel in one of the 4 regions: main left artery, LAD, LCX and RCA including their branches; No CV -- mean number of calcified major coronary vessels.

For TCS \>0 and CV \> 1 data are number (%) of patients.

The incidence of acute and chronic events by TCS categories is given in Table [3](#T3){ref-type="table"} and Figure [1](#F1){ref-type="fig"}. During follow-up incidence of the CAD events (all types pooled together) rose consequently from 2% in subjects without CAC to 34% in subjects with the highest CAC category TCS \> 600 AU (p \< 0.001). However, different pattern in the development of the first acute and chronic coronary events in accordance with the CAC category was observed. Among the 32 subjects with TCS \> 600 AU, 11 (34%) developed chronic event while none of them had acute event. In contrast, none of subjects with TCS = 0 or TCS 1--100 AU had chronic events. Subjects with TCS 101--600 AU presented 10 (9%) chronic and 5 (4.5%) acute events (p \< 0.001).

![**Incidence of acute and chronic events by TCS categories.** TCS - Total calcium score (AU).](1475-2840-12-161-1){#F1}

###### 

Incidence of acute and chronic events by TCS categories

  **Type of event**   **TCS = 0**   **TCS 1--100**   **TCS 101--600**   **TCS \> 600**   **p value**
  ------------------- ------------- ---------------- ------------------ ---------------- -------------
  All types           5 (2)         8 (4)            15 (13.5)          11 (34)          \<0.001
  Acute               5 (2)         8 (4)            5 (4.5)            0                
  Chronic             0             0                10 (9)             11 (34)           

Data are number (%) of patients.

TCS - Total calcium score (AU).

Discussion
==========

The main finding of our study is that asymptomatic subjects with ECAC, both with and without DM did not developed first acute CAD-related events during up to 10 years of follow-up. Our data support the suggestion that ECAC is associated with a stable form of atherosclerosis which is mainly manifested by a chronic rather than acute course of CAD \[[@B7]-[@B9]\].

Previous studies have shown a dramatically increased incidence rate of CAD events (when all types of events pooled together) among those with the highest levels of CAC compared to those with CAC = zero \[[@B3]-[@B6]\]. However, as we demonstrate in the current analysis, a different pattern in development of acute and chronic coronary events in accordance with CAC category can be distinguished. The acute events in our study occurred mostly in subjects with mild and moderate CAC and even in absence of CAC. This might have an important clinical relevance, since minimal or mild CAC should not be categorized into a lower risk category (as suggested by the SHAPE investigators) \[[@B17]\]. These findings are also supported by histopathological studies, intravascular ultrasound and CT observations that consistently demonstrated that acute events rise mainly from soft non-calcified or mildly calcified plaques \[[@B18]-[@B27]\]. In a series of cases of sudden coronary death, more than 50% of thin-cap fibroatheromas showed a lack of calcification or only speckled calcification on postmortem radiographs of coronary arteries \[[@B18]\]. Several studies demonstrated the destabilizing effect of the lipid core, whereas presence of calcium was a stabilizing force and calcified lesions were more resistant to rupture (similar to fibrous plaque) \[[@B19],[@B20]\].

Thus, it seems that ECAC represents a long standing chronic stage of slowly growing coronary atherosclerosis and can be regarded as a healing process leading to stabilization and decrease vulnerability of the plaques \[[@B28]\]. On the other hand, ECAC causes negative vessels remodeling resulting in flow restriction and leading to clinical manifestations such as chronic angina or silent ischemia upon a routine stress test \[[@B18]-[@B28]\].

The prevalence of CAC in our patients with DM was significantly higher than in patients without DM. The clinical value of CAC score in diabetic patients has been recently demonstrated in several studies: CAC score can further stratify diabetic patients according to the presence and extent of CAC into patients with very low or high CV risk \[[@B10]-[@B13],[@B29]\].

It should be stated that our population was predominantly masculine, and this may represent a potential limitation since the epicardial adipose tissue volume shows gender disparities, being strongly associated with coronary atherosclerosis in men \[[@B30]\]. Therefore, despite of the strong theoretical background and biological plausibility, caution should be used in interpreting our findings because it was not a randomized controlled trial and we cannot rule out other factors that could have influenced the observed clinical outcomes.

Conclusions
===========

Asymptomatic subjects with ECAC did not develop first acute events, but presented a high level of chronic CAD-related events during a long term follow-up. In contrast, most of the acute CAD-related events firstly occurred in subjects with mild and moderate CAC.
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